Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Epidemiology and Population Health

Association between obesity and combination antiretroviral therapy (cART) adherence among persons with early-stage HIV infection initiating cART

Abstract

Background

Obesity is common among people living with HIV (PLWH) and early-stage infection, yet associations with combination antiretroviral (cART) adherence are unclear.

Methods

Among PLWH initiating cART in Uganda and South Africa, body mass index (BMI) was assessed at cART initiation, and cART adherence was monitored in real-time over 12 months. The association of obesity (BMI ≥ 30 kg/m2) with adherence was assessed among nonpregnant participants with CD4 > 350 cells/mm3 using fractional regression modeling.

Results

Among 322 participants, median age was 32 years, 70% were female, and 54% were from Uganda. Prevalence of obesity was 12% in Uganda and 28% in South Africa. Mean overall cART adherence was 83% in Uganda and 66% in South Africa. Participants with obesity had higher adherence than those without obesity: +3.6% (p = 0.44) in Uganda and +11.4% (p = 0.02) in South Africa.

Conclusion

Obesity at cART initiation was common and associated with higher adherence, although only significantly in South Africa.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Collaborators GBDO, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377:13–27.

    Article  Google Scholar 

  2. WHO. Global Health Observatory (GHO) data. https://www.who.int/data/gho/data/indicators/indicator-details/GHO/prevalence-ofoverweight-among-adults-bmi-=-25-(age-standardized-estimate)-(-).

  3. Guehi C, Badje A, Gabillard D, Ouattara E, Koule SO, Moh R, et al. High prevalence of being Overweight and Obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial. AIDS Res Ther. 2016;13:12.

    Article  Google Scholar 

  4. WHO. HIV/AIDS. In: Key facts; 2019.

  5. Coetzee L, Bogler L, De Neve JW, Barnighausen T, Geldsetzer P, Vollmer S. HIV, antiretroviral therapy and non-communicable diseases in sub-Saharan Africa: empirical evidence from 44 countries over the period 2000 to 2016. J Int AIDS Soc. 2019;22:e25364.

    Article  Google Scholar 

  6. Biggs C, Spooner E. Obesity and HIV: a compounding problem. South Afr J Clin Nutr. 2018;31:78–83.

    Article  Google Scholar 

  7. Bailin SS, Gabriel CL, Wanjalla CN, Koethe JR. Obesity and weight gain in persons with HIV. Curr HIV/AIDS Rep. 2020;17:138–150.

    Article  Google Scholar 

  8. Venter WDF, Moorhouse M, Sokhela S, Fairlie L, Mashabane N, Masenya M, et al. Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV. N Engl J Med. 2019;381:803–815.

    Article  CAS  Google Scholar 

  9. Kumar S, Samaras K. The impact of weight gain during HIV treatment on risk of pre-diabetes, diabetes mellitus, cardiovascular disease, and mortality. Front Endocrinol. 2018;9:705.

    Article  Google Scholar 

  10. Haberer JE, Bwana BM, Orrell C, Asiimwe S, Amanyire G, Musinguzi N, et al. ART adherence and viral suppression are high among most non-pregnant individuals with early-stage, asymptomatic HIV infection: an observational study from Uganda and South Africa. J Int AIDS Soc. 2019;22:e25232.

    Article  Google Scholar 

  11. Mayega RW, Etajak S, Rutebemberwa E, Tomson G, Kiguli J. ‘Change means sacrificing a good life’: perceptions about severity of type 2 diabetes and preventive lifestyles among people afflicted or at high risk of type 2 diabetes in Iganga Uganda. BMC Public Health. 2014;14:864.

    Article  Google Scholar 

  12. Lambert RF, Orrell C, Bangsberg DR, Haberer JE. Factors that motivated otherwise healthy HIV-positive young adults to access HIV testing and treatment in South Africa. AIDS Behav. 2018;22:733–741.

    Article  Google Scholar 

  13. Zheng W, McLerran DF, Rolland B, Zhang X, Inoue M, Matsuo K, et al. Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med. 2011;364:719–729.

    Article  CAS  Google Scholar 

  14. Manne-Goehler J, Baisley K, Vandormael A, Bärnighausen T, Tanser F, Herbst K, et al. BMI and All-Cause Mortality in a Population-Based Cohort in Rural South Africa. Obesity. 2020;28:2414–23. https://doi.org/10.1002/oby.23005.

    Article  PubMed  Google Scholar 

  15. Heerden Iv. Mieliepap (maize meal porridge) and the glycaemic index. Health. 2013;24. https://www.health24.com/Diet-and-nutrition/Nutrition-basics/Mieliepap-maize-meal-porridge-and-the-glycaemic-index-20130210.

  16. Tsai AC, Bangsberg DR, Emenyonu N, Senkungu JK, Martin JN, Weiser SD. The social context of food insecurity among persons living with HIV/AIDS inrural Uganda. Soc Sci Med 2011,73:1717–24.

  17. Bolton P, Wilk CM, Ndogoni L. Assessment of depression prevalence in rural Uganda using symptom and function criteria. Soc Psychiatry Psychiatr Epidemiol 2004,39:442–7.

  18. Bradley KA, DeBenedetti AF, Volk RJ, Williams EC, Frank D, Kivlahan DR. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res 2007,31:1208–17.

  19. Jeyaseelan L, Kumar S, Mohanraj R, Rebekah G, Rao D, Manhart LE. Assessing HIV/AIDS stigma in south India: validation and abridgement of the Berger HIV Stigma scale. AIDS Behav 2013,17:434–43.

Download references

Funding

This study was supported by the Bill and Melinda Gates Foundation (OPP1056051). Authors report the following additional support: P30DK040561 (FCS), L30DK118710 (FCS), K23HD097300 (AAB), and the Massachusetts General Hospital Executive Committee on Research through the Center for Diversity and Inclusion (AAB).

META team

Bosco M. Bwana1,9, Gideon Amanyire1,10, Lynn T. Matthews11,12, Alexander C. Tsai11,12, Ingrid T. Katz12,13, Kathleen Bell11, Annet Kembabazi1, Stephen Mugisha1, Victoria Kibirige1, Anna Cross14, Nicola Kelly14, Bethany Hedt-Gauthier11,12, David R. Bangsberg15

Author information

Authors and Affiliations

Authors

Consortia

Corresponding author

Correspondence to Nicholas Musinguzi.

Ethics declarations

Conflict of interest

JEH reports consulting fees from Merck. The other authors declare no competing financial interests

Ethics statement

Ethical review boards at Mbarara University of Science and Technology, Uganda National Council Science and Technology, the University of Cape Town and Partners Healthcare approved the META study. All participants provided written informed consent.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Members of the META team are listed below Funding.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Musinguzi, N., Stanford, F.C., Boatin, A.A. et al. Association between obesity and combination antiretroviral therapy (cART) adherence among persons with early-stage HIV infection initiating cART. Int J Obes 45, 1855–1859 (2021). https://doi.org/10.1038/s41366-021-00837-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41366-021-00837-y

Search

Quick links